|
1
|
George PBL, Rossi F, St-Germain MW, Amato P, Badard T, Bergeron MG, Boissinot M, Charette SJ, Coleman BL, Corbeil J, Culley AI, Gaucher ML, Girard M, Godbout S, Kirychuk SP, Marette A, McGeer A, O’Shaughnessy PT, Parmley EJ, Simard S, Reid-Smith RJ, Topp E, Trudel L, Yao M, Brassard P, Delort AM, Larios AD, Létourneau V, Paquet VE, Pedneau MH, Pic É, Thompson B, Veillette M, Thaler M, Scapino I, Lebeuf M, Baghdadi M, Castillo Toro A, Cayouette AB, Dubois MJ, Durocher AF, Girard SB, Diaz AKC, Khalloufi A, Leclerc S, Lemieux J, Maldonado MP, Pilon G, Murphy CP, Notling CA, Ofori-Darko D, Provencher J, Richer-Fortin A, Turgeon N, Duchaine C. Antimicrobial Resistance in the Environment: Towards Elucidating the Roles of Bioaerosols in Transmission and Detection of Antibacterial Resistance Genes. Antibiotics (Basel) 2022; 11:antibiotics11070974. [PMID: 35884228 PMCID: PMC9312183 DOI: 10.3390/antibiotics11070974] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 06/30/2022] [Accepted: 07/15/2022] [Indexed: 02/01/2023] Open
Abstract
Antimicrobial resistance (AMR) is continuing to grow across the world. Though often thought of as a mostly public health issue, AMR is also a major agricultural and environmental problem. As such, many researchers refer to it as the preeminent One Health issue. Aerial transport of antimicrobial-resistant bacteria via bioaerosols is still poorly understood. Recent work has highlighted the presence of antibiotic resistance genes in bioaerosols. Emissions of AMR bacteria and genes have been detected from various sources, including wastewater treatment plants, hospitals, and agricultural practices; however, their impacts on the broader environment are poorly understood. Contextualizing the roles of bioaerosols in the dissemination of AMR necessitates a multidisciplinary approach. Environmental factors, industrial and medical practices, as well as ecological principles influence the aerial dissemination of resistant bacteria. This article introduces an ongoing project assessing the presence and fate of AMR in bioaerosols across Canada. Its various sub-studies include the assessment of the emissions of antibiotic resistance genes from many agricultural practices, their long-distance transport, new integrative methods of assessment, and the creation of dissemination models over short and long distances. Results from sub-studies are beginning to be published. Consequently, this paper explains the background behind the development of the various sub-studies and highlight their shared aspects.
Collapse
Affiliation(s)
- Paul B. L. George
- Département de Médecine Moléculaire, Université Laval, Quebec City, QC G1V 0A6, Canada; (P.B.L.G.); (J.C.); (I.S.)
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
| | - Florent Rossi
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Chimie de Clermont-Ferrand, SIGMA Clermont, CNRS, Université Clermont-Auvergne, 63178 Clermont-Ferrand, France; (P.A.); (A.-M.D.)
| | - Magali-Wen St-Germain
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Pierre Amato
- Institut de Chimie de Clermont-Ferrand, SIGMA Clermont, CNRS, Université Clermont-Auvergne, 63178 Clermont-Ferrand, France; (P.A.); (A.-M.D.)
| | - Thierry Badard
- Centre de Recherche en Données et Intelligence Géospatiales (CRDIG), Quebec City, QC G1V 0A6, Canada;
| | - Michel G. Bergeron
- Centre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Axe Maladies Infectieuses et Immunitaires, Quebec City, QC G1V 4G2, Canada; (M.G.B.); (M.B.); (É.P.)
| | - Maurice Boissinot
- Centre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Axe Maladies Infectieuses et Immunitaires, Quebec City, QC G1V 4G2, Canada; (M.G.B.); (M.B.); (É.P.)
| | - Steve J. Charette
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Brenda L. Coleman
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada; (B.L.C.); (A.M.)
| | - Jacques Corbeil
- Département de Médecine Moléculaire, Université Laval, Quebec City, QC G1V 0A6, Canada; (P.B.L.G.); (J.C.); (I.S.)
- Centre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Axe Maladies Infectieuses et Immunitaires, Quebec City, QC G1V 4G2, Canada; (M.G.B.); (M.B.); (É.P.)
| | - Alexander I. Culley
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Marie-Lou Gaucher
- Research Chair in Meat Safety, Département de Pathologie et Microbiologie, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada;
| | | | - Stéphane Godbout
- Institut de Recherche et de Développement en Agroenvironnement (IRDA), Quebec City, QC G1P 3W8, Canada; (S.G.); (A.D.L.); (A.K.C.D.)
- Département des Sols et de Génie Agroalimentaire, Université Laval, Quebec City, QC G1V 0A6, Canada;
| | - Shelley P. Kirychuk
- Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada; (S.P.K.); (B.T.); (A.C.T.); (C.A.N.)
| | - André Marette
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
- Institut sur la Nutrition et les Aliments Fonctionnels, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Allison McGeer
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada; (B.L.C.); (A.M.)
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada
| | - Patrick T. O’Shaughnessy
- Department of Occupational and Environmental Health, The University of Iowa, Iowa City, IA 52246, USA;
| | - E. Jane Parmley
- Canadian Wildlife Health Cooperative, University of Guelph, Guelph, ON N1G 2W1, Canada;
- Department of Population Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada; (R.J.R.-S.); (M.P.M.)
| | - Serge Simard
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Richard J. Reid-Smith
- Department of Population Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada; (R.J.R.-S.); (M.P.M.)
- Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada; (C.P.M.); (D.O.-D.)
| | - Edward Topp
- Agriculture and Agri-Food Canada, London Research and Development Centre, London, ON N5V 4T3, Canada;
- Department of Biology, The University of Western Ontario, London, ON N6A 5B7, Canada
| | - Luc Trudel
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
| | - Maosheng Yao
- State Key Joint Laboratory of Environmental Simulation and Pollution Control, College of Environmental Sciences and Engineering, Peking University, Beijing 100871, China;
| | - Patrick Brassard
- Département des Sols et de Génie Agroalimentaire, Université Laval, Quebec City, QC G1V 0A6, Canada;
| | - Anne-Marie Delort
- Institut de Chimie de Clermont-Ferrand, SIGMA Clermont, CNRS, Université Clermont-Auvergne, 63178 Clermont-Ferrand, France; (P.A.); (A.-M.D.)
| | - Araceli D. Larios
- Institut de Recherche et de Développement en Agroenvironnement (IRDA), Quebec City, QC G1P 3W8, Canada; (S.G.); (A.D.L.); (A.K.C.D.)
- Tecnológico Nacional de México/ITS de Perote, Perote 91270, Mexico
| | - Valérie Létourneau
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Valérie E. Paquet
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Marie-Hélène Pedneau
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Émilie Pic
- Centre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Axe Maladies Infectieuses et Immunitaires, Quebec City, QC G1V 4G2, Canada; (M.G.B.); (M.B.); (É.P.)
| | - Brooke Thompson
- Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada; (S.P.K.); (B.T.); (A.C.T.); (C.A.N.)
| | - Marc Veillette
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Mary Thaler
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Ilaria Scapino
- Département de Médecine Moléculaire, Université Laval, Quebec City, QC G1V 0A6, Canada; (P.B.L.G.); (J.C.); (I.S.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Maria Lebeuf
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Mahsa Baghdadi
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Alejandra Castillo Toro
- Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada; (S.P.K.); (B.T.); (A.C.T.); (C.A.N.)
| | - Amélia Bélanger Cayouette
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Marie-Julie Dubois
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
- Institut sur la Nutrition et les Aliments Fonctionnels, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Alicia F. Durocher
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Sarah B. Girard
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Andrea Katherín Carranza Diaz
- Institut de Recherche et de Développement en Agroenvironnement (IRDA), Quebec City, QC G1P 3W8, Canada; (S.G.); (A.D.L.); (A.K.C.D.)
- Département des Sols et de Génie Agroalimentaire, Université Laval, Quebec City, QC G1V 0A6, Canada;
| | - Asmaâ Khalloufi
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Research Chair in Meat Safety, Département de Pathologie et Microbiologie, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada;
| | - Samantha Leclerc
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Joanie Lemieux
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
- Centre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Axe Maladies Infectieuses et Immunitaires, Quebec City, QC G1V 4G2, Canada; (M.G.B.); (M.B.); (É.P.)
| | - Manuel Pérez Maldonado
- Department of Population Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada; (R.J.R.-S.); (M.P.M.)
| | - Geneviève Pilon
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada
| | - Colleen P. Murphy
- Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada; (C.P.M.); (D.O.-D.)
| | - Charly A. Notling
- Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0X8, Canada; (S.P.K.); (B.T.); (A.C.T.); (C.A.N.)
| | - Daniel Ofori-Darko
- Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada; (C.P.M.); (D.O.-D.)
| | - Juliette Provencher
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Institut de Biologie Intégrative et des Systèmes, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Annabelle Richer-Fortin
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Nathalie Turgeon
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
| | - Caroline Duchaine
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Université Laval, Quebec City, QC G1V 0A6, Canada; (F.R.); (M.-W.S.-G.); (S.J.C.); (A.I.C.); (L.T.); (V.E.P.); (M.T.); (M.B.); (A.B.C.); (A.F.D.); (S.B.G.); (A.K.); (S.L.); (J.L.); (J.P.); (A.R.-F.)
- Centre de Recherche de L’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC G1V 4G5, Canada; (A.M.); (S.S.); (V.L.); (M.-H.P.); (M.V.); (M.L.); (M.-J.D.); (G.P.); (N.T.)
- Correspondence:
| |
Collapse
|
|
2
|
Houde N, Beuret L, Bonaud A, Fortier-Beaulieu SP, Truchon-Landry K, Aoidi R, Pic É, Alouche N, Rondeau V, Schlecht-Louf G, Balabanian K, Espéli M, Charron J. Fine-tuning of MEK signaling is pivotal for limiting B and T cell activation. Cell Rep 2022; 38:110223. [PMID: 35021072 DOI: 10.1016/j.celrep.2021.110223] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2020] [Revised: 10/05/2021] [Accepted: 12/15/2021] [Indexed: 01/17/2023] Open
Abstract
MEK1 and MEK2, the only known activators of ERK, are attractive therapeutic candidates for both cancer and autoimmune diseases. However, how MEK signaling finely regulates immune cell activation is only partially understood. To address this question, we specifically delete Mek1 in hematopoietic cells in the Mek2 null background. Characterization of an allelic series of Mek mutants reveals the presence of distinct degrees of spontaneous B cell activation, which are inversely proportional to the levels of MEK proteins and ERK activation. While Mek1 and Mek2 null mutants have a normal lifespan, 1Mek1 and 1Mek2 mutants retaining only one functional Mek1 or Mek2 allele in hematopoietic cell lineages die from glomerulonephritis and lymphoproliferative disorders, respectively. This establishes that the fine-tuning of the ERK/MAPK pathway is critical to regulate B and T cell activation and function and that each MEK isoform plays distinct roles during lymphocyte activation and disease development.
Collapse
Affiliation(s)
- Nicolas Houde
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada
| | - Laurent Beuret
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada
| | - Amélie Bonaud
- Université de Paris, Institut de Recherche Saint Louis, EMiLy, INSERM U1160, Paris 75010, France; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris 75010, France
| | - Simon-Pierre Fortier-Beaulieu
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada
| | - Kim Truchon-Landry
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada
| | - Rifdat Aoidi
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada
| | - Émilie Pic
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada
| | - Nagham Alouche
- Université de Paris, Institut de Recherche Saint Louis, EMiLy, INSERM U1160, Paris 75010, France; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris 75010, France
| | - Vincent Rondeau
- Université de Paris, Institut de Recherche Saint Louis, EMiLy, INSERM U1160, Paris 75010, France; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris 75010, France
| | - Géraldine Schlecht-Louf
- Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, Clamart 92140, France
| | - Karl Balabanian
- Université de Paris, Institut de Recherche Saint Louis, EMiLy, INSERM U1160, Paris 75010, France; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris 75010, France
| | - Marion Espéli
- Université de Paris, Institut de Recherche Saint Louis, EMiLy, INSERM U1160, Paris 75010, France; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris 75010, France
| | - Jean Charron
- Centre de Recherche sur le Cancer de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval (Oncology Axis), L'Hôtel-Dieu de Québec, 9, Rue McMahon, Québec, QC G1R 3S3 Canada; Department of Molecular Biology, Medical Biochemistry & Pathology, Université Laval, Québec, QC G1V 0A6, Canada.
| |
Collapse
|
|
3
|
Burgain A, Pic É, Markey L, Tebbji F, Kumamoto CA, Sellam A. A novel genetic circuitry governing hypoxic metabolic flexibility, commensalism and virulence in the fungal pathogen Candida albicans. PLoS Pathog 2019; 15:e1007823. [PMID: 31809527 PMCID: PMC6919631 DOI: 10.1371/journal.ppat.1007823] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Revised: 12/18/2019] [Accepted: 10/18/2019] [Indexed: 01/04/2023] Open
Abstract
Inside the human host, the pathogenic yeast Candida albicans colonizes predominantly oxygen-poor niches such as the gastrointestinal and vaginal tracts, but also oxygen-rich environments such as cutaneous epithelial cells and oral mucosa. This suppleness requires an effective mechanism to reversibly reprogram the primary metabolism in response to oxygen variation. Here, we have uncovered that Snf5, a subunit of SWI/SNF chromatin remodeling complex, is a major transcriptional regulator that links oxygen status to the metabolic capacity of C. albicans. Snf5 and other subunits of SWI/SNF complex were required to activate genes of carbon utilization and other carbohydrates related process specifically under hypoxia. snf5 mutant exhibited an altered metabolome reflecting that SWI/SNF plays an essential role in maintaining metabolic homeostasis and carbon flux in C. albicans under hypoxia. Snf5 was necessary to activate the transcriptional program linked to both commensal and invasive growth. Accordingly, snf5 was unable to maintain its growth in the stomach, the cecum and the colon of mice. snf5 was also avirulent as it was unable to invade Galleria larvae or to cause damage to human enterocytes and murine macrophages. Among candidates of signaling pathways in which Snf5 might operate, phenotypic analysis revealed that mutants of Ras1-cAMP-PKA pathway, as well as mutants of Yak1 and Yck2 kinases exhibited a similar carbon flexibility phenotype as did snf5 under hypoxia. Genetic interaction analysis indicated that the adenylate cyclase Cyr1, a key component of the Ras1-cAMP pathway interacted genetically with Snf5. Our study yielded new insight into the oxygen-sensitive regulatory circuit that control metabolic flexibility, stress, commensalism and virulence in C. albicans. A critical aspect of eukaryotic cell fitness is the ability to sense and adapt to variations in oxygen level in their local environment. Hypoxia leads to a substantial remodeling of cell metabolism and energy homeostasis, and thus, organisms must develop an effective regulatory mechanism to cope with oxygen depletion. Candida albicans is an opportunistic yeast that is the most prevalent human fungal pathogens. This yeast colonizes diverse niches inside the human host with contrasting carbon sources and oxygen concentrations. While hypoxia is the predominant condition that C. albicans encounters inside most of the niches, the impact of this condition on metabolic flexibility, a major determinant of fungal virulence, was completely unexplored. Here, we uncovered that the chromatin remodelling complex SWI/SNF is a master regulator of the circuit that links oxygen status to a broad spectrum of carbon utilization routes. Snf5 was essential for the maintenance of C. albicans as a commensal and also for the expression of its virulence. The oxygen-sensitive regulators identified in this work provide a framework to comprehensively understand the virulence of human fungal pathogens and represent a therapeutic value to fight fungal infections.
Collapse
Affiliation(s)
- Anaïs Burgain
- CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada
- Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada
| | - Émilie Pic
- CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada
| | - Laura Markey
- Program in Molecular Microbiology, Tufts University, Boston, Massachusetts, United States of America
- Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America
| | - Faiza Tebbji
- CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada
| | - Carol A. Kumamoto
- Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America
| | - Adnane Sellam
- CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada
- Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada
- Big Data Research Centre (BDRC-UL), Université Laval, Faculty of Sciences and Engineering, Quebec City, Quebec, Canada
- * E-mail:
| |
Collapse
|
|
5
|
Krietsch J, Rouleau M, Pic É, Ethier C, Dawson TM, Dawson VL, Masson JY, Poirier GG, Gagné JP. Reprogramming cellular events by poly(ADP-ribose)-binding proteins. Mol Aspects Med 2013; 34:1066-87. [PMID: 23268355 PMCID: PMC3812366 DOI: 10.1016/j.mam.2012.12.005] [Citation(s) in RCA: 111] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2012] [Revised: 12/12/2012] [Accepted: 12/14/2012] [Indexed: 12/23/2022]
Abstract
Poly(ADP-ribosyl)ation is a posttranslational modification catalyzed by the poly(ADP-ribose) polymerases (PARPs). These enzymes covalently modify glutamic, aspartic and lysine amino acid side chains of acceptor proteins by the sequential addition of ADP-ribose (ADPr) units. The poly(ADP-ribose) (pADPr) polymers formed alter the physico-chemical characteristics of the substrate with functional consequences on its biological activities. Recently, non-covalent binding to pADPr has emerged as a key mechanism to modulate and coordinate several intracellular pathways including the DNA damage response, protein stability and cell death. In this review, we describe the basis of non-covalent binding to pADPr that has led to the emerging concept of pADPr-responsive signaling pathways. This review emphasizes the structural elements and the modular strategies developed by pADPr-binding proteins to exert a fine-tuned control of a variety of pathways. Poly(ADP-ribosyl)ation reactions are highly regulated processes, both spatially and temporally, for which at least four specialized pADPr-binding modules accommodate different pADPr structures and reprogram protein functions. In this review, we highlight the role of well-characterized and newly discovered pADPr-binding modules in a diverse set of physiological functions.
Collapse
Affiliation(s)
- Jana Krietsch
- Centre de recherche du CHUQ – Pavillon CHUL – Cancer Axis, Laval University, Québec, QC, Canada G1V 4G2
- Genome Stability Laboratory, Laval University Cancer Research Center, Hôtel-Dieu de Québec, Québec, QC, Canada G1R 2J6
| | - Michèle Rouleau
- Centre de recherche du CHUQ – Pavillon CHUL – Cancer Axis, Laval University, Québec, QC, Canada G1V 4G2
- Department of Molecular Biology, Cellular Biochemistry and Pathology, Faculty of Medicine, Laval University, Québec, QC, Canada G1V 0A6
| | - Émilie Pic
- Centre de recherche du CHUQ – Pavillon CHUL – Cancer Axis, Laval University, Québec, QC, Canada G1V 4G2
| | - Chantal Ethier
- Centre de recherche du CHUQ – Pavillon CHUL – Cancer Axis, Laval University, Québec, QC, Canada G1V 4G2
| | - Ted M. Dawson
- Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
| | - Valina L. Dawson
- Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
- Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
| | - Jean-Yves Masson
- Genome Stability Laboratory, Laval University Cancer Research Center, Hôtel-Dieu de Québec, Québec, QC, Canada G1R 2J6
- Department of Molecular Biology, Cellular Biochemistry and Pathology, Faculty of Medicine, Laval University, Québec, QC, Canada G1V 0A6
| | - Guy G. Poirier
- Centre de recherche du CHUQ – Pavillon CHUL – Cancer Axis, Laval University, Québec, QC, Canada G1V 4G2
- Department of Molecular Biology, Cellular Biochemistry and Pathology, Faculty of Medicine, Laval University, Québec, QC, Canada G1V 0A6
| | - Jean-Philippe Gagné
- Centre de recherche du CHUQ – Pavillon CHUL – Cancer Axis, Laval University, Québec, QC, Canada G1V 4G2
| |
Collapse
|